Revenue-Generating Placement to Serve as Live Demonstration of Safe Entry Station to Tier-1 Government Agencies and Event Organizers
Toronto, ON – August 26, 2021 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced the revenue-generating deployment of four (4) Safe Entry Stations at the Palm Tree Music Festival to be held August 29, 2021 in Westhampton Beach, NY, as part of the Company’s reseller partnership with the U.S.-based JUICEWORKS.
The venue will serve as a unique opportunity to demonstrate the Company’s proprietary AI-enabled screening solution to representatives from local, state and federal government agencies, the military and tier-1 event organizers in attendance. The single-day Palm Tree Music Festival will be an intimate festival experience designed to capture the unmatched feeling of summer in paradise with majestic beach vibes and unmissable sets by a lineup of global icons.
The Palm Tree Crew partnered with Predictmedix and Northwell Health, New York’s largest Health Care provider, to design a safety protocol for attendees. Upon arrival, guests and staff will be required to show proof of vaccination, along with a current PCR test. They will then walk through the Predictmedix Safe Entry Station to rapidly identify multiple symptoms of infectious diseases such as COVID-19, displaying the result in the form of a red or green light.
“We knew that in order to bring this festival to life and provide a safe environment, we needed to partner with leaders in health and tech,” said Myles Shear, Co-Founder of Palm Tree Crew. “We built Palm Tree Crew to create game-changing business ventures and I’m glad that we are able to partner with Predictmedix for this event.”
“We are rapidly becoming the preferred onsite solution for large scale live events globally, and the Palm Tree Music Festival represents an ideal opportunity to further showcase our technology to a variety of potential government and event organizer customers,” said Dr. Rahul Kushwah, Chief Operating Officer at Predictmedix. “We expect to meet with multiple representatives from the armed forces, local, state and federal governments, government agencies, private security companies and major event providers to explain how they can utilize our proprietary AI algorithm to provide rapid, robust, and non-invasive screening, including multi-symptom detection of infectious diseases such as COVID-19. We look forward to the event as a real time use case for these potential customers and to protect the attendees at this exciting festival.”
About Predictmedix Inc.
Predictmedix (CSE: PMED) (OTCQB: PMEDF) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations – powered by a proprietary artificial intelligence (AI) – use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, or various mental illnesses. Predictmedix’s proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at www.Predictmedix.com or follow us on Twitter, Instagram or LinkedIn.
Caution Regarding Forward-Looking Information:
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the company, including risks related to COVID-19; risks related to the Company’s shares, including price volatility due to events that may or may not be within such party’s control; reliance on management; and the emergency of additional competitors in the industry.
All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.
The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.